Dr. Salari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Massachusetts General Hospital
55 Fruit St., GRB-1109A
Boston, MA 02114- Is this information wrong?
Summary
- Dr. Keyan Salari is a urologic oncologist in Boston, MA and is affiliated with Massachusetts General Hospital and Harvard Medical School. He received his medical degree from Stanford University School of Medicine and trained at Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. He has been in practice 7 years. He is experienced in urology, oncology, and cancer genomics.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2018 - 2019
- Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 2014 - 2018
- Massachusetts General HospitalInternship, Surgery, 2012 - 2013
- Stanford University School of MedicineClass of 2012, M.D.
- Stanford UniversityPh.D., Genetics, 2010
- University of California, BerkeleyB.A., Molecular and Cell Biology, 2004
Certifications & Licensure
- NH State Medical License 2021 - 2025
- MA State Medical License 2012 - 2024
- RI State Medical License 2021 - 2024
- ME State Medical License 2020 - 2024
- NY State Medical License 2017 - 2019
- American Board of Urology Urology
Publications & Presentations
PubMed
- Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.Florian Rumpf, Anna Plym, Jane B Vaselkiv, Kathryn L Penney, Lorelei A Mucci, Mark A Preston, Adam S Kibel, Keyan Salari> ;The Journal of Urology. 2024 Apr 10
- Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prosta...Andrew E Amini, Alexandra E Hunter, Aya Almashad, Aileen J Feng, Neel D Patel, Margaret R O'Dea, Shelley R McCormick, Linda H Rodgers, Keyan Salari> ;European Urology Oncology. 2024 Mar 6
- Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology.Andrew E Amini, Keyan Salari> ;JCO Precision Oncology. 2024 Feb 1
- Join now to see all
Journal Articles
- Detection of Pathogenic Variants with Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients with Prostate Cancer and MelanomaKeyan Salari, MD, JAMA
Press Mentions
- Genomic Urine Test Detects Bladder Cancer from DNA up to 12 Years Before Clinical Signs and Symptoms AppearMay 1st, 2023
- Role of HRD in Early-Stage Prostate CancerMay 31st, 2022
- Metabolic Syndrome Post-Prostatectomy Ups Prostate Cancer Death RiskSeptember 12th, 2021
- Join now to see all
Professional Memberships
- American Urological AssociationMember
Other Languages
- Spanish, Farsi
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
- Newton-Wellesley HospitalNewton Lower Falls, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: